Following an academic background at Harvard, MIT, and Caltech, inventing over 100 patents and applications, founding two prior companies with a combined 185 employees, spending 2 years as a part-time partner at Y Combinator, investing in and advising numerous biotechs, and publishing a Science paper in biophysics, Joe is now the CEO of Retro Biosciences, which uses high-throughput, high-dimensional approaches to develop therapies for diseases driven by the biology of aging.